(Q45839929)

16 December 2017

title

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection (English)

1 reference

16 December 2017

1 reference

1 reference

1 reference

G J Alexander

1

1 reference

16 December 2017

J Brahm

2

1 reference

16 December 2017

E A Fagan

3

1 reference

16 December 2017

H M Smith

4

1 reference

16 December 2017

H M Daniels

5

1 reference

16 December 2017

A L Eddleston

6

1 reference

16 December 2017

R Williams

7

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 July 1987

1 reference

16 December 2017

published in

The Lancet

1 reference

16 December 2017

volume

2

1 reference

16 December 2017

issue

8550

1 reference

16 December 2017

page(s)

66-69

1 reference

16 December 2017

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Long-term follow-up of chronic hepatitis patients with HBsAg, HBeAg and Dane particles associated DNA polymerase in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Interferon therapy of chronic hepatitis B virus infection in Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

A virus in Beechey ground squirrels that is related to hepatitis B virus of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Quantitation of hepatitis B virus DNA (HBV DNA) in serum using the spot hybridization technique and scintillation counting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Interferons with Special Emphasis on the Immune System

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

The mode of action of interferons in viral infections and their possible role in the control of hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

1 reference

7 January 2021

T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

Interferon in viral hepatitis: role in pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992735-8

7 January 2021

10.1016/S0140-6736(87)92735-8

Identifiers

DOI

1 reference

16 December 2017

PubMed ID

2885573

1 reference

16 December 2017